The growth response to GH treatment is greater in patients with SHOX enhancer deletions compared to SHOX defects

S.H. Donze, C.R. Meijer, S.G. Kant, G.R.J. Zandwijken, A.H. van der Hout, R.M.L. van Spaendonk, A.M.W. van den Ouweland, J.M. Wit, M. Losekoot, W. Oostdijk

Research output: Contribution to journalArticleAcademicpeer-review

20 Citations (Scopus)
Original languageEnglish
Pages (from-to)611-621
JournalEuropean journal of endocrinology
Issue number5
Publication statusPublished - 2015

Cite this